Wed 30 November 2022:   The experimental drug lecanemab has the “potential” to serve as treatment at early stages of Alzheimer’s disease, according to new trial results. The drug’s developers, Biogen from the U.S. and Eisai from Japan, published results of the study on Tuesday showing the drug as one of the first experimental drugs that … Continue reading EXPERIMENTAL DRUG SLOWS PROGRESSION OF ALZHEIMER’S: STUDY